?PD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid Tumors
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Mesothelioma
- Non -Small Cell Lung Cancer
- Type
- Interventional
- Phase
- Early Phase 1
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 70 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04489862
- Collaborators
- Shanghai Cell Therapy Group Co.,Ltd
- Investigators
- Principal Investigator: Xiaorong Dong Wuhan Union Hospital, China
Get Well Soon